ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664529 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664529; 2) Community: the network communities that were significantly associated with the response to NSC 664529; 3) Molecule: the relationships between components within communities and NSC 664529; 4) MDR: the compounds that were significantly associated with the NSC 664529.

NSC Compound Enrichment Correlation
NSC 703315 Null 0.000706163530262832 -0.080670759
NSC 716281 Null 0.000706163530262832 -0.23029272
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.000706163530262832 0.44995349
NSC 740252 Null 0.000710545569439725 0.30816604
NSC 174121 Methotrexate Derivative 0.000710545569439728 0.38060521
NSC 150289 Null 0.000762764599619747 0.43443043
NSC 134754 Null 0.000778243021198122 0.22098246
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.000778243021198122 0.1969457
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.000778243021198122 0.38706253
NSC 372944 Null 0.000778243021198122 0.23814119
Total:121  Current:6    [First] [Prev] [Next] [Last]